Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:January 12, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:January 12, 2023Terminated
Condition(s):Diabetes; Type 2 Diabetes MellitusLast Updated:June 11, 2019Completed
Condition(s):Atrial Septal Defects; Patent Ductus ArteriosusLast Updated:August 19, 2015Unknown status
Condition(s):Chronic Hepatitis C Virus (HCV) Infection Genotype 1Last Updated:April 7, 2023Completed
Condition(s):Prostate Cancer; Castration-resistant Prostate Cancer; Metastatic Prostate CancerLast Updated:December 20, 2019Completed
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:July 20, 2022Completed
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:March 26, 2019Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:January 21, 2015Completed
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:July 20, 2022Completed
Condition(s):Acute Heart FailureLast Updated:November 14, 2018Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.